What is Smile
The goal of the study is to demonstrate a significant decrease in the rate of Heart Failure (HF) re-hospitalizations, based on ReDS-SensiVest™ directed treatment as an adjunct to standard of care, during the entire randomized follow-up period. Patients are enrolled during an index hospitalization of ADHF and are followed for a period of 3 to 9 months.
JOIN THE STUDY
AS A PATIENT
If you suffer from Heart Failure,
please ask your physician about